Konjestif Kalp Yetmezliği, Hipertansiyon, Tip 2 Diyabet, Kardiyomegali ve Akromegalisi Olan Hastanın Gordon’un Fonksiyonel Sağlık Örüntüleri Modeli ve Nanda Hemşirelik Tanılarına Göre Hemşirelik Bakımı: Olgu Sunumu
Yazar :
Özet
Yaşamı tehdit eden, hastane ortamında bakım ve tedavi gerektiren, mortalite ve morbidite artışına neden olan konjestif kalp yetmezliği (KKY) ile pankreasın ürettiği insülinin vücut tarafından etkili bir şekilde kullanılamaması ya da insülin sekresyonundaki bozukluk ile karakterize, hiperglisemi ile seyreden Tip 2 diyabet, patofizyolojik olarak birbiri ile bağlantılı kronik hastalıklardır. Tip 2 diyabet ve hipertansiyon da ateroskleroz kaynaklı kardiyovasküler hastalıkların toplum içinde yayılmasına neden olan birbiriyle ilişkili hastalıklardır. Yine kalbin hem dilatasyonu hem hipertrofisi olan kardiyomegali ile büyüme hormonu fazlalığından kaynaklanan akromegali klinik bir sendrom olarak birbirleri ile bağlantılıdır. Birbiri ile ilişkili komplike tanıları olan hastalarda yaşam kalitesinin arttırılması ve komplikasyonların önlenmesi için standardize edilmiş hemşirelik bakımının uygulanması gereklidir. Bu olgu sunumunda KKY, hipertansiyon, Tip 2 diyabet, kardiyomegali ve akromegali tanıları olan bir hastanın hemşirelik bakımı, Gordon’un Fonksiyonel Sağlık Örüntüleri (FSÖ) Modeli ve Kuzey Amerikan Hemşirelik Tanıları Birliği (NANDA) hemşirelik tanıları kullanılarak sunulmuştur. Olgunun verileri, hasta bakımı sırasında yapılan gözlemler ve hasta ile yapılan görüşmelerden elde edilerek toplanmış, modele göre bakım içeriği planlanarak uygulanmış ve elde edilen sonuçlar değerlendirilmiştir. Hastaya sunulan holistik hemşirelik bakımı ile olumlu sonuçlar elde edilmiştir.
Anahtar Kelimeler
Özet
Life-threatening, require care and treatment in a hospital environment, the leading cause of mortality and morbidity cause of congestive heart failure (CHF) with the insulin the pancreas produces insulin secretion impairment, or inability to use efficiently by the body, which is characterized by hyperglycemia of Type 2 diabetes are chronic diseases that are connected each other as pathophysiological. Type 2 diabetes and hypertension are also interrelated diseases that lead to the spread of cardiovascular diseases caused by atherosclerosis in society. Yet, cardiomegaly is both dilatation and hypertrophy of the heart, and acromegaly caused by an excess of growth hormone, are related to each other as a clinical syndrome. In order to improve the quality of life and prevent complications in patients with complicated diagnoses associated with each other, it is necessary to apply standardized nursing care. In this case report, the nursing care of congestive heart failure, hypertension, Type 2 diabetes, cardiomegaly, acromegaly patient is presented using the Functional Health Patterns Model (FHP) and the North American Association of Nursing Diagnostics (NANDA) nursing diagnoses. The data of the case was collected from the observations made during patient care and interviews with the patient, the care content was planned and applied according to the model and the results were evaluated. Positive results were obtained with the holistic nursing care offered to the patient.
Anahtar Kelimeler
- American Diabetes Association. (2021). Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes-2021. Diabetes Care, 44(1), 111-124.
- American Heart Association. (2017). What is Heart Failure? Retrieved February 12, 2022, from https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure.
- Amin, H., & Siddiqui, W.J. (2022). Cardiomegaly. [Updated 2021 Aug 11]. In: Stat- Pearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. Retrieve January 30, 2022, from https://www.ncbi.nlm.nih.gov/books/NBK542296/.
- Barkan, A.L., Burman, P., Clemmons, D.R., Drake W.M., Gagel, R.F., Harris P.E., … Vance, M.L. (2005). Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant. The Journal of Clinical Endocrinology and Metabolism, 90(10), 5684-5691.
- Borde-Perry, W.C., Campbell, K.L., Murtaugh, K.H., Gidding, S., & Falkner, B. (2002). The association between hypertension and other cardiovascular risk factors in young adult African Americans. Journal of Clinical Hypertension, 4(1), 1722.
- Bui, A.L., Horwich, T.B., & Fonarow, G.C. (2011). Epidemiology and risk profile of heart failure. Nature Reviews Cardiology, 8(1), 30-41.
- Cowie M.R., Anker S.D., Cleland, J.G.F., Felker G.M., Filippatos, G., Jaarsma, T., … López-Sendón, J. (2014). Improving care for patients with acute heart failure: Before, during and after hospitalization. ESC Heart Fail, 1(2), 110-145.
- Dal, J., Feldt-Rasmussen, U., Andersen, M., Kristensen, L.O., Laurberg, P., Pedersen L., … Jørgensen, J.O. (2016). Acromegaly incidence, prevalence, complications and long-term prognosis: A nationwide cohort study. European Journal of Endocrinology, 175(3), 90-181.
- Desai, A.S., McMurray, J.J., Packer, M., Swedberg, K., Rouleau, J.L., Chen, F., …Solo- mon, S.D. (2015). Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. European Heart Journal, 36(30), 1990-1997.
- Dunlay, S.M., Givertz, M.M., Aguilar, D., Allen, L.A., Chan, M., Desai, A.S., …Piña, I.L. (2019). Type 2 diabetes mellitus and heart failure a scientific statement from the American Heart Association and the Heart Failure Society of America. Circulation, 140(12), 692.
- Ergani, N.R.I., & Helena, F.A. (2022). A case study of a 54-year-old man with NYHA Class III, Stage 2 Hypertension, and Type II Diabetes Mellitus. Diponegoro Medical Journal, 11(1), 64-69.
- Hannon, A.M., Thompson, C.J., & Sherlock, M. (2017). Diabetes in patients with acromegaly. Current Diabetes Reports, 17(2),1-8.
- Gordon, M. (1994). Nursing diagnosis: Process and application (3rd ed). St Luis: Mosby, USA.
- International Diabetes Federation. (2021). IDF Diabetes Atlas. Retrieved February 09, 2022, from https://diabetesatlas.org/.
- Le, Y., Wang, B., & Xue, M. (2022). Nutraceuticals use and type 2 diabetes mellitus. Current Opinion in Pharmacology, 62, 168-176.
- Liu, T., Luo, J., He, H., Zheng, J., Zhao, J., & Li, K. (2018). History-taking instruction for baccalaureate nursing students by virtual patient training: A retrospective study. Nurse Education Today, 71, 97-104.
- Packer, M. (2017). Activation and inhibition of sodium-hydrogen exchanger is a mechanism that links the pathophysiology and treatment of diabetes mellitus with that of heart failure. Circulation, 136(16), 1548-1559.
- Rachamin, Y., Meier, R., Rosemann, T., Flammer, A.J., & Chmiel, C. (2021). Heart fai- lure epidemiology and treatment in primary care: A retrospective crosssectional study. ESC Heart Fail, 8(1), 489-497.
- Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., …Wil- liams, R. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice, 157(2019), 107843.
- Savarese, G., & Lund, L.H. (2017). Global public health burden of heart failure. Card Fail Rev, 3(1), 7-11.
